메뉴 건너뛰기




Volumn 8, Issue 2, 2002, Pages 96-101

Fenofibrate or gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: A randomized, double-blind, crossover study

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CREATINE KINASE; CREATININE; ESTROGEN; FAT; FENOFIBRATE; FIBRINOGEN; GEMFIBROZIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LEVOTHYROXINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; PROGESTERONE; THYROTROPIN; TRIACYLGLYCEROL; URIC ACID;

EID: 0036127492     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.8.2.96     Document Type: Article
Times cited : (36)

References (16)
  • 4
    • 0023232216 scopus 로고
    • Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia; safety of treatment, changes in risk factors, and incidence of coronary heart disease
    • (1987) N. Engl. J. Med. , vol.317 , pp. 1237-1245
    • Frick, M.H.1    Elo, O.2    Haapa, K.3
  • 5
    • 0033527030 scopus 로고    scopus 로고
    • Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
    • (Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group).
    • (1999) N. Engl. J. Med. , vol.342 , pp. 410-418
    • Rubins, H.B.1    Robins, S.J.2    Collins, D.3
  • 6
    • 25044433850 scopus 로고
    • Respective hypolipidemic potency of various new fibrates in regard to multiple lipoprotein parameters
    • Presented at: 8th Symposium on Atherosclerosis; Rome.
    • (1982)
    • De Gennes, J.L.1    Dairou, F.2    Truffert, J.3
  • 11
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study)
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3
  • 13
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 14
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • (Cholesterol and Recurrent Events Trial Investigators).
    • (1996) N. Engl. J. Med. , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 15
    • 0034158506 scopus 로고    scopus 로고
    • The American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis
    • AACE Lipid Guidelines Committee.
    • (2000) Endocr. Pract. , vol.6 , pp. 162-213
  • 16
    • 0035941990 scopus 로고    scopus 로고
    • Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study; a randomised study
    • [erratum in Lancet. 2001;357:1890]
    • (2001) Lancet , vol.357 , pp. 905-910


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.